Amgen (NASDAQ:AMGN) today announced TEPEZZA® (JAN: Teprotumumab (Genetical Recombination)) has been approved for the treatment of active or high clinical activity score (CAS) Thyroid Eye Disease (TED) ...
SGS is also accredited with ISO 17025 and ISO 17020, which reflects their competence, impartiality, and consistency in operations. Additionally, it is verified by the Non-GMO Project to conduct GMO ...